In 1382 patients given IV thrombolysis for ischaemic stroke (NIHSS 4-10), aspirin plus ticagrelor started within 6 h vs placebo increased excellent 90-day outcome (68.7% vs 62.0%; RR 1.11). Symptomatic ICH was 0.9% vs 0.7% (not significant).
RCTn = 1,382
Wang et al. Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial